查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555691

心血管保健品市场，按补充剂类型、形式、分布、人口统计、国家和地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Cardiovascular Health Supplements Market, By Supplement Type, By Form, By Distribution, By Demographics, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 367 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年，心血管保健品市场规模为112.3423亿美元，2024年至2032年复合年增长率为8.98%。

心血管保健品市场-市场动态

全球对心血管疾病的认识和盛行率的提高推动了心血管保健品市场的成长

全球对心血管疾病的认识不断增强，加上其盛行率不断上升，大大增加了对心血管保健品的需求。根据世界卫生组织 (WHO) 的数据，心血管疾病是全球主要死亡原因，每年约导致 1,790 万人死亡。这项令人震惊的统计数据促使公共和私人卫生组织推广预防措施，包括使用 omega-3 脂肪酸和 CoQ10 等补充剂。例如，美国心臟协会建议将特定的膳食补充剂作为心臟健康生活方式的一部分，反映了预防性保健的更广泛趋势。此外，疾病预防控制中心的一份报告强调，美国近一半的成年人患有某种形式的心血管疾病，这进一步强调了迫切需要采取干预措施（包括补充剂）来管理和减少与心臟病相关的危险因子。

心血管保健品市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 8.98% 左右的复合年增长率成长

根据补充剂类型细分，预计 Omega-3 脂肪酸将在 2023 年显示最大的市场份额

按形态细分，胶囊为2023年主导类型

从分销细分来看，2023年线上零售为主导类型

按地区划分，北美是 2023 年的主要收入来源

心血管保健品市场-細項分析：

全球心血管保健品市场根据补充剂类型、形式、分布、人口统计和地区进行细分。

根据补充剂类型，市场分为五类：Omega-3 脂肪酸、辅酶 Q10、纤维补充剂、植物固醇和抗氧化剂。 Omega-3 脂肪酸因其支持心臟健康的有力证据而引领心血管保健补充剂市场，其次是辅酶 Q10 和植物固醇，因为它们越来越受欢迎。纤维补充剂和抗氧化剂的优先顺序较低，但仍然必不可少。

市场依剂型分为五类：药片、胶囊、粉末、液体补充剂和软糖。胶囊和片剂因其便利性和稳定性而在心血管保健品市场占据主导地位，其次是剂量灵活的粉末。液体补充剂越来越受欢迎，而软糖虽然不太受重视，但吸引了特定消费者的偏好。

心血管保健品市场-地理洞察

北美在市场上占据主导地位，这主要是由于高意识水平、先进的医疗保健系统以及对预防性医疗保健的高度重视。美国尤其在该地区处于领先地位，有很大一部分人口定期使用心臟保健补充剂。欧洲紧随其后，由于人口老化和心血管疾病发生率上升，德国和英国等国家的采用率不断提高。在亚太地区，受可支配收入增加、城市化和健康意识增强的推动，市场正在迅速扩张，特别是在中国、日本和印度等国家。然而，拉丁美洲和非洲等地区的市场渗透率仍然较低，这些地区的主要挑战是认识和获取补充剂的机会有限。儘管如此，随着意识和经济状况的改善，这些地区提供了尚未开发的市场成长机会。

心血管保健品市场-竞争格局：

主要行业参与者包括雅培实验室、安丽、拜耳公司和康宝莱营养品等知名公司，它们利用强大的品牌知名度、广泛的分销网络和强大的研发能力。这些公司专注于产品创新，通常会结合 omega-3 脂肪酸、辅酶 Q10 和植物固醇等有科学依据的成分，以使其产品脱颖而出。此外，许多参与者正在扩大其产品组合，包括针对个人健康需求量身定制的个人化补充剂，从而吸引更广泛的消费者群体。该市场还面临来自小型专业公司的激烈竞争，这些公司以独特的配方和天然成分迎合利基市场。随着公司寻求增强其市场影响力和地理覆盖范围，策略合作伙伴关係、合併和收购很常见。儘管竞争激烈，但对心臟保健补充剂不断增长的需求继续为新进者和现有参与者提供充足的机会。

最新进展：

2023 年 6 月，Healthycell 推出了心臟和血管健康产品，这是一种超可吸收的凝胶补充剂，旨在支持正常的胆固醇、三酸甘油酯和血压水平。它结合了植物成分和维生素，在单一凝胶包中提供简单、无药物的心臟健康解决方案。

2023 年 7 月，英国 Dr. Vegan 推出了两款新补充剂：含有植物固醇的用于心血管支持的 HeartPro，以及含有益生菌的用于女性阴道健康的 pH Hero。此次推出扩大了品牌的植物性产品范围，以满足消费者对天然、合乎道德的补充剂日益增长的需求。

目录

第一章：心血管保健品市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 心血管保健品市场摘要（按补充剂类型）
    • 心血管保健品市场摘要（按形式）
    • 心血管保健品市场片段（依分布）
    • 按人口统计的心血管保健品市场片段
    • 按国家/地区分類的心血管保健品市场摘要
    • 按地区分類的心血管保健品市场片段
  • 竞争洞察

第 3 章：心血管保健品主要市场趋势

  • 心血管保健品市场驱动因素
    • 市场驱动因素的影响分析
  • 心血管保健品市场限制
    • 市场限制影响分析
  • 心血管保健品市场机会
  • 心血管保健品市场未来趋势

第 4 章：心血管保健品产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：心血管保健品市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：心血管保健品市场格局

  • 2023 年心血管保健品市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：心血管保健品市场 - 依补充剂类型

  • 概述
    • 按补充剂类型分類的细分市场份额分析
    • Omega-3 脂肪酸
    • 辅酶Q10
    • 纤维补充剂
    • 植物固醇
    • 抗氧化剂

第 8 章：心血管保健品市场 - 按形式

  • 概述
    • 细分市场占有率分析（按形式）
    • 平板电脑
    • 胶囊
    • 粉末
    • 液体补充剂
    • 软糖

第 9 章：心血管保健品市场 - 按分布

  • 概述
    • 按分布分類的细分市场占有率分析
    • 网路零售
    • 保健食品店
    • 药局
    • 超市
    • 直销

第 10 章：心血管保健品市场 - 按人口统计

  • 概述
    • 按人口统计资料进行细分市场占有率分析
    • 成年人
    • 老年
    • 孩子们
    • 特定健康状况

第 11 章：心血管保健品市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美心血管保健品主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按补充剂类型）
    • 北美市场规模及预测（按形式）
    • 北美市场规模和预测（按分布）
    • 北美市场规模和预测（按人口统计）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲心血管保健品主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按补充剂类型）
    • 欧洲市场规模与预测（按形式）
    • 欧洲市场规模与预测（按分布）
    • 欧洲市场规模和预测（按人口统计）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区心血管保健品主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模和预测（按补充剂类型）
    • 亚太地区市场规模与预测（按形式）
    • 亚太地区市场规模与预测（按分布）
    • 亚太地区市场规模与预测（依人口统计）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲心血管保健品主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模和预测（按补充剂类型）
    • 拉丁美洲市场规模与预测（按形式）
    • 拉丁美洲市场规模与预测（按分布）
    • 拉丁美洲市场规模与预测（按人口统计）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲心血管保健品主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按补充类型）
    • 中东和非洲市场规模及预测（按形式）
    • 中东和非洲市场规模及预测（按分布）
    • 中东和非洲市场规模及预测（按人口统计）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 12 章：主要供应商分析 - 心血管保健品产业

  • 竞争仪表板
  • 公司简介
    • Pfizer Inc.
    • Nature's Bounty Co.
    • Herbalife Nutrition Ltd.
    • Amgen Inc.
    • GNC Holdings, Inc.
    • BASF SE
    • Abbott Laboratories
    • GlaxoSmithKline plc
    • DSM Nutritional Products
    • The Nature's Way Products, LLC
    • Nutrilite (Amway)
    • MegaFood (FoodState)
    • Now Foods
    • Solgar Inc.
    • Blackmores Limited
    • Thrive Market
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV3701

REPORT HIGHLIGHT

Cardiovascular Health Supplements Market size was valued at USD 11,234.23 Million in 2023, expanding at a CAGR of 8.98% from 2024 to 2032.

The Cardiovascular Health Supplements Market focuses on products aimed at supporting heart health through various nutritional formulations, including omega-3 fatty acids, CoQ10, and plant sterols. Rising awareness about cardiovascular diseases, coupled with increasing incidences of heart-related conditions due to lifestyle changes, has fueled demand for these supplements. Growing consumer inclination towards preventive healthcare and the ageing global population further intensify this trend. However, the market faces challenges like stringent regulatory requirements and skepticism regarding the efficacy of these supplements. Opportunities lie in developing innovative products, such as personalized supplements, and expanding distribution channels.

Cardiovascular Health Supplements Market- Market Dynamics

Increasing Global Awareness and Prevalence of Cardiovascular Diseases Propel Cardiovascular Health Supplements Market Growth

The growing global awareness of cardiovascular diseases, coupled with their rising prevalence, has significantly boosted the demand for cardiovascular health supplements. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for approximately 17.9 million deaths annually. This alarming statistic has driven both public and private health organizations to promote preventive measures, including the use of supplements like omega-3 fatty acids and CoQ10. For instance, the American Heart Association has recommended the inclusion of specific dietary supplements as part of a heart-healthy lifestyle, reflecting the broader trend toward preventive healthcare. Furthermore, a report from the CDC highlighted that nearly half of all adults in the United States have some form of cardiovascular disease, further underlining the critical need for interventions, including supplementation, to manage and reduce risk factors associated with heart conditions.

Cardiovascular Health Supplements Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.98% over the forecast period (2024-2032)

Based on Supplement Type segmentation, Omega-3 Fatty Acids was predicted to show maximum market share in the year 2023

Based on Form segmentation, Capsules was the leading type in 2023

Based on distribution segmentation, Online Retail was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Cardiovascular Health Supplements Market- Segmentation Analysis:

The Global Cardiovascular Health Supplements Market is segmented based on Supplement Type, Form, Distribution, Demographics, and Region.

The market is divided into five categories based on Supplement Type: Omega-3 Fatty Acids, Coenzyme Q10, Fiber Supplements, Plant Sterols, and Antioxidants. Omega-3 fatty acids lead the cardiovascular health supplement market due to their strong evidence in supporting heart health, followed by Coenzyme Q10 and Plant Sterols for their growing popularity. Fiber Supplements and Antioxidants rank lower in priority, yet remain essential.

The market is divided into five categories based on Form: Tablets, Capsules, Powders, Liquid Supplements, and Gummies. Capsules and Tablets dominate the Cardiovascular Health Supplements market due to their convenience and stability, followed by Powders for flexible dosing. Liquid Supplements are gaining traction, while Gummies, though less prioritized, appeal to specific consumer preferences.

Cardiovascular Health Supplements Market- Geographical Insights

North America dominates the market, largely due to high awareness levels, advanced healthcare systems, and a strong focus on preventive healthcare. The U.S., in particular, leads the region, with a substantial portion of the population regularly using heart health supplements. Europe follows closely, with countries like Germany and the UK witnessing growing adoption driven by an ageing population and increasing incidences of cardiovascular diseases. In the Asia-Pacific region, the market is expanding rapidly, fueled by rising disposable incomes, urbanization, and growing health consciousness, particularly in countries like China, Japan, and India. However, market penetration remains lower in regions like Latin America and Africa, where limited awareness and access to supplements are key challenges. Nonetheless, these regions present untapped opportunities for market growth as awareness and economic conditions improve.

Cardiovascular Health Supplements Market- Competitive Landscape:

Key industry participants include established companies like Abbott Laboratories, Amway, Bayer AG, and Herbalife Nutrition, which leverage strong brand recognition, extensive distribution networks, and robust research and development capabilities. These companies are focused on product innovation, often incorporating scientifically-backed ingredients such as omega-3 fatty acids, CoQ10, and plant sterols to differentiate their offerings. Additionally, many players are expanding their product portfolios to include personalized supplements tailored to individual health needs, thereby attracting a broader consumer base. The market also sees significant competition from smaller, specialized companies that cater to niche markets with unique formulations and natural ingredients. Strategic partnerships, mergers, and acquisitions are common as companies seek to enhance their market presence and geographic reach. Despite the intense competition, the growing demand for heart health supplements continues to provide ample opportunities for new entrants and existing players alike.

Recent Developments:

In June 2023, Healthycell launched Heart & Vascular Health, an ultra-absorbable gel supplement aimed at supporting normal cholesterol, triglyceride, and blood pressure levels. It combines plant-based ingredients and vitamins, offering an easy, drug-free heart health solution in a single gel pack.

In July 2023, UK-based Dr. Vegan launched two new supplements: HeartPro for cardiovascular support with plant sterols, and pH Hero for women's vaginal health with probiotics. The launch expands the brand's plant-based offerings to meet growing consumer demand for natural, ethical supplements.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Pfizer Inc.
  • Nature's Bounty Co.
  • Herbalife Nutrition Ltd.
  • Amgen Inc.
  • GNC Holdings, Inc.
  • BASF SE
  • Abbott Laboratories
  • GlaxoSmithKline plc
  • DSM Nutritional Products
  • The Nature's Way Products, LLC
  • Nutrilite (Amway)
  • MegaFood (FoodState)
  • Now Foods
  • Solgar Inc.
  • Blackmores Limited
  • Thrive Market
  • Others

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY SUPPLEMENT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Omega-3 Fatty Acids
  • Coenzyme Q10
  • Fiber Supplements
  • Plant Sterols
  • Antioxidants

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY FORM- MARKET ANALYSIS, 2019 - 2032

  • Tablets
  • Capsules
  • Powders
  • Liquid Supplements
  • Gummies

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

  • Online Retail
  • Health Food Stores
  • Pharmacies
  • Supermarkets
  • Direct Sales

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY DEMOGRAPHICS- MARKET ANALYSIS, 2019 - 2032

  • Adults
  • Elderly
  • Children
  • Specific Health Conditions

GLOBAL CARDIOVASCULAR HEALTH SUPPLEMENTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cardiovascular Health Supplements Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cardiovascular Health Supplements Market Snippet by Supplement Type
    • 2.1.2. Cardiovascular Health Supplements Market Snippet by Form
    • 2.1.3. Cardiovascular Health Supplements Market Snippet by Distribution
    • 2.1.4. Cardiovascular Health Supplements Market Snippet by Demographics
    • 2.1.5. Cardiovascular Health Supplements Market Snippet by Country
    • 2.1.6. Cardiovascular Health Supplements Market Snippet by Region
  • 2.2. Competitive Insights

3. Cardiovascular Health Supplements Key Market Trends

  • 3.1. Cardiovascular Health Supplements Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cardiovascular Health Supplements Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cardiovascular Health Supplements Market Opportunities
  • 3.4. Cardiovascular Health Supplements Market Future Trends

4. Cardiovascular Health Supplements Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cardiovascular Health Supplements Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Cardiovascular Health Supplements Market Landscape

  • 6.1. Cardiovascular Health Supplements Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cardiovascular Health Supplements Market - By Supplement Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Supplement Type, 2023 & 2032 (%)
    • 7.1.2. Omega-3 Fatty Acids
    • 7.1.3. Coenzyme Q10
    • 7.1.4. Fiber Supplements
    • 7.1.5. Plant Sterols
    • 7.1.6. Antioxidants

8. Cardiovascular Health Supplements Market - By Form

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Form, 2023 & 2032 (%)
    • 8.1.2. Tablets
    • 8.1.3. Capsules
    • 8.1.4. Powders
    • 8.1.5. Liquid Supplements
    • 8.1.6. Gummies

9. Cardiovascular Health Supplements Market - By Distribution

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
    • 9.1.2. Online Retail
    • 9.1.3. Health Food Stores
    • 9.1.4. Pharmacies
    • 9.1.5. Supermarkets
    • 9.1.6. Direct Sales

10. Cardiovascular Health Supplements Market - By Demographics

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Demographics, 2023 & 2032 (%)
    • 10.1.2. Adults
    • 10.1.3. Elderly
    • 10.1.4. Children
    • 10.1.5. Specific Health Conditions

11. Cardiovascular Health Supplements Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Cardiovascular Health Supplements Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Cardiovascular Health Supplements Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Cardiovascular Health Supplements Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Cardiovascular Health Supplements Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Cardiovascular Health Supplements Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Supplement Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Form, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Demographics, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Cardiovascular Health Supplements Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Pfizer Inc.
    • 12.2.2. Nature's Bounty Co.
    • 12.2.3. Herbalife Nutrition Ltd.
    • 12.2.4. Amgen Inc.
    • 12.2.5. GNC Holdings, Inc.
    • 12.2.6. BASF SE
    • 12.2.7. Abbott Laboratories
    • 12.2.8. GlaxoSmithKline plc
    • 12.2.9. DSM Nutritional Products
    • 12.2.10. The Nature's Way Products, LLC
    • 12.2.11. Nutrilite (Amway)
    • 12.2.12. MegaFood (FoodState)
    • 12.2.13. Now Foods
    • 12.2.14. Solgar Inc.
    • 12.2.15. Blackmores Limited
    • 12.2.16. Thrive Market
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us